• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用预测模型中的临界点来实施列线图的使用:2012 年更新版的 Partin 表格与前列腺癌器官局限疾病的欧洲预测列线图比较。

Implementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ-confined disease in prostate cancer.

机构信息

Department of Urology, Hospital Universitario 'Miguel Servet', Zaragoza, Spain.

出版信息

BJU Int. 2014 Jun;113(6):878-86. doi: 10.1111/bju.12532. Epub 2014 Feb 14.

DOI:10.1111/bju.12532
PMID:24529282
Abstract

OBJECTIVES

To implement the use of nomograms in clinical practice showing how to choose thresholds in nomograms' predictions to select risk groups. To validate and compare the predictive ability and clinical utility of the Hospital Universitario 'Miguel Servet' (HUMS) and the updated Partin Tables 2012 (PT-2012) nomograms to predict organ-confined disease (OCD) after radical prostatectomy (RP).

PATIENTS AND METHODS

Cohort of 1285 patients with prostate cancer treated with RP at Instituto Valenciano de Oncología (IVO) between 1986 and 2011. The predictive value of the nomograms was assessed by means of calibration curves, discrimination ability (area under the receiver operating characteristic (ROC) curve (AUC) and probability density functions). The clinical utility was evaluated through Vickers' decision curves and thresholds were chosen through probability density functions.

RESULTS

The calibration curves showed a minimal underestimation in low probabilities (<20%), a minimal overestimation in high probabilities (>50%) in the HUMS nomogram and a regular minimal overestimation in the PT-2012. Their AUC of 0.7285 (95% confidence interval [CI] 0.7010-0.7559) and 0.7288 (95%CI 0.7013-0.7562) respectively, show an adequate discrimination ability for both predictive models in the IVO cohort. The decision curves show similar net benefits for both models. In this study we advocate for a threshold of 53% for the identification of OCD.

CONCLUSIONS

The HUMS-nomogram and the PT-2012 predictions of OCD confirm their utility in a contemporary cohort of patients. Patients with a probability of OCD >53% should be classified as OCD, helping physicians to better counsel their patients. A selection of adequate thresholds, as presented in this paper, makes nomograms more accessible tools.

摘要

目的

介绍列线图在临床实践中的应用,展示如何选择列线图预测的阈值来划分风险组。验证和比较“米格尔·塞尔韦特大学医院”(HUMS)和更新的 2012 年帕丁表(PT-2012)列线图预测根治性前列腺切除术(RP)后器官局限性疾病(OCD)的预测能力和临床实用性。

患者和方法

该队列包括 1986 年至 2011 年在瓦伦西亚肿瘤研究所(IVO)接受 RP 治疗的 1285 例前列腺癌患者。通过校准曲线、鉴别能力(接受者操作特征曲线(ROC)下面积(AUC)和概率密度函数)评估列线图的预测价值。通过维克斯决策曲线评估临床实用性,并通过概率密度函数选择阈值。

结果

校准曲线显示,HUMS 列线图在低概率(<20%)时低估最小,在高概率(>50%)时高估最小,而在 PT-2012 中则出现常规性最小高估。在 IVO 队列中,这两个预测模型的 AUC 分别为 0.7285(95%置信区间 [CI] 0.7010-0.7559)和 0.7288(95%CI 0.7013-0.7562),表明这两个预测模型都具有较好的鉴别能力。决策曲线显示两种模型的净获益相似。本研究主张将 53%作为识别 OCD 的阈值。

结论

HUMS 列线图和 PT-2012 对 OCD 的预测在当代患者队列中证实了其有效性。应将 OCD 概率>53%的患者归类为 OCD,以帮助医生更好地为患者提供咨询。本文提出的适当阈值选择使列线图成为更易获得的工具。

相似文献

1
Implementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ-confined disease in prostate cancer.应用预测模型中的临界点来实施列线图的使用:2012 年更新版的 Partin 表格与前列腺癌器官局限疾病的欧洲预测列线图比较。
BJU Int. 2014 Jun;113(6):878-86. doi: 10.1111/bju.12532. Epub 2014 Feb 14.
2
External validation of a Brazilian predictive nomogram for pathologic outcomes following radical prostatectomy in tertiary teaching institutions: the USP nomograms.巴西预测模型在三级教学医院前列腺根治性切除术后病理结局的外部验证:USP 列线图。
Int Braz J Urol. 2014 Mar-Apr;40(2):161-71. doi: 10.1590/S1677-5538.IBJU.2014.02.05.
3
Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.使用2005年国际泌尿病理学会关于Gleason分级的共识,对日本临床局限性前列腺癌患者进行Partin表验证及术前列线图的开发:来自局限性前列腺癌临床病理研究组的数据
J Urol. 2008 Sep;180(3):904-9; discussion 909-10. doi: 10.1016/j.juro.2008.05.047. Epub 2008 Jul 17.
4
Genetic predisposition to early recurrence in clinically localized prostate cancer.临床局限性前列腺癌早期复发的遗传倾向。
BJU Int. 2013 Apr;111(4):549-58. doi: 10.1111/j.1464-410X.2012.11333.x. Epub 2012 Jul 3.
5
Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.三种常用于预测根治性前列腺切除术时淋巴结侵犯的术前工具的头对头比较。
Urology. 2011 Dec;78(6):1363-7. doi: 10.1016/j.urology.2011.07.1423.
6
Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.列线图预测接受广泛盆腔淋巴结清扫术的前列腺癌患者淋巴结侵犯概率的头对头比较。
Urology. 2012 Mar;79(3):546-51. doi: 10.1016/j.urology.2011.11.036.
7
External validation of the Briganti nomogram to estimate the probability of specimen-confined disease in patients with high-risk prostate cancer.用于评估高危前列腺癌患者标本局限性疾病概率的Briganti列线图的外部验证。
BJU Int. 2014 Dec;114(6b):E113-E119. doi: 10.1111/bju.12763. Epub 2014 Aug 13.
8
Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models.确定根治性前列腺切除术后癌症特异性死亡率的最具信息性预测工具:三种常用术前预测模型的比较分析。
Eur Urol. 2016 Jun;69(6):1038-43. doi: 10.1016/j.eururo.2015.07.051. Epub 2015 Aug 10.
9
Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.盆腔淋巴结清扫的范围和标准模板解剖对淋巴结受累诺莫图预测的影响。
Eur Urol. 2011 Aug;60(2):195-201. doi: 10.1016/j.eururo.2011.01.016. Epub 2011 Jan 18.
10
Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis.列线图预测韩国男性临床局限性前列腺癌的病理分期:与西方预测工具的决策曲线分析比较。
Int J Urol. 2012 Sep;19(9):846-52. doi: 10.1111/j.1442-2042.2012.03040.x. Epub 2012 May 15.

引用本文的文献

1
The Role of Digital Rectal Examination Prostate Volume Category in the Early Detection of Prostate Cancer: Its Correlation with the Magnetic Resonance Imaging Prostate Volume.直肠指检前列腺体积分类在前列腺癌早期检测中的作用:其与磁共振成像前列腺体积的相关性
World J Mens Health. 2024 Apr;42(2):441-448. doi: 10.5534/wjmh.230028. Epub 2024 Jan 2.
2
Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer.用于预测临床显著前列腺癌的鹿特丹和巴塞罗那磁共振成像风险计算器的比较
Eur Urol Open Sci. 2023 May 22;53:46-54. doi: 10.1016/j.euros.2023.03.013. eCollection 2023 Jul.
3
A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand.
一种利用直肠指检前列腺体积分类来分层初始前列腺癌怀疑并减少磁共振成像需求的具有临床意义的前列腺癌预测模型。
Cancers (Basel). 2022 Oct 18;14(20):5100. doi: 10.3390/cancers14205100.
4
Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.鉴定预测肝细胞癌总生存期的 13 基因标志物。
Biosci Rep. 2021 Apr 30;41(4). doi: 10.1042/BSR20202870.
5
How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies.如何在临床实践中实施前列腺活检前的磁共振成像:节省活检的列线图。
World J Urol. 2020 Jun;38(6):1481-1491. doi: 10.1007/s00345-019-02946-w. Epub 2019 Sep 10.
6
RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer-From Cell Line Models to Liquid Biopsies.RNA作为前列腺癌的候选诊断和预后标志物——从细胞系模型到液体活检
Diagnostics (Basel). 2018 Aug 30;8(3):60. doi: 10.3390/diagnostics8030060.
7
Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage.根据临床和病理特征,局限性前列腺癌中 DNA 修复基因突变的流行情况:与 Gleason 评分和肿瘤分期的关系。
Prostate Cancer Prostatic Dis. 2019 Mar;22(1):59-65. doi: 10.1038/s41391-018-0086-1. Epub 2018 Aug 31.
8
The management of active surveillance in prostate cancer: validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry.前列腺癌主动监测的管理:使用西班牙泌尿外科学会登记处对金丝雀前列腺主动监测研究风险计算器进行验证。
Oncotarget. 2017 Oct 24;8(65):108451-108462. doi: 10.18632/oncotarget.21984. eCollection 2017 Dec 12.
9
Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.优化前列腺癌抗原3(PCA3)在初次前列腺活检中诊断前列腺癌的临床应用价值。
BMC Cancer. 2015 Sep 11;15:633. doi: 10.1186/s12885-015-1623-0.
10
Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy.用于预测接受放疗加雄激素剥夺治疗的前列腺癌生化复发的三个关联列线图。
Strahlenther Onkol. 2015 Oct;191(10):792-800. doi: 10.1007/s00066-015-0866-7. Epub 2015 Jul 9.